Concepedia
Statistics
Publications
19
Citations
2.4K
H-Index
17
Active since
2001
Affiliations
AbbVie (United States)(Current)
Vanderbilt University
Icahn School of Medicine at Mount Sinai
University of Pennsylvania
Sanford Burnham Prebys Medical Discovery Institute
Kenneth D. Bromberg is an author at AbbVie (United States) specializing in medicine, cell biology, and natural sciences.
Top concepts
MedicineCell BiologyBiochemistryCell SignalingNatural SciencesPharmacologyDrug DiscoverySystems BiologyMolecular BiologySignal Transduction
Publications per year
2001–2021
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren Lasko, Clarissa G. Jakob, Rohinton Edalji et al. · Nature · 2017 · 813 citations · Full text
Lineage-specific Tumours, Medicine, Immune Checkpoint Inhibitor +8
Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome
Brian T. Weinert, Takeo Narita, Shankha Satpathy et al. · Cell · 2018 · 511 citations · Full text
Biochemistry, Natural Sciences, Molecular Biology +3
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
Simon J. Hogg, Olga Motorna, Leonie A. Cluse et al. · Molecular Cell · 2021 · 157 citations · Full text
A Two-drug Model for Etoposide Action against Human Topoisomerase IIα
Kenneth D. Bromberg, Alex B. Burgin, Neil Osheroff · Journal of Biological Chemistry · 2003 · 142 citations · Full text
Design Logic of a Cannabinoid Receptor Signaling Network That Triggers Neurite Outgrowth
Kenneth D. Bromberg, Avi Ma’ayan, Susana R. Neves et al. · Science · 2008 · 140 citations · Full text
Neurotransmission, Gene Regulatory Network, Cannabinoid Pharmacology +20
1–5 of 19